Resistance Trends of Klebsiella pneumoniae Causing Urinary Tract Infections in Chongqing, 2011–2019

References

• Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. doi:10.1038/nrmicro343225853778
   PubMed Web of Science ®Google Scholar
• Ikram R, Psutka R, Carter A, Priest P. An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: a case-control study of risk factors. BMC Infect Dis. 2015;15:224–230. doi:10.1186/s12879-015-0974-026054866
   PubMed Web of Science ®Google Scholar
• Sun JD, Huang SF, Yang SS, Pu SL, Zhang CM, Zhang LP. Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. Clin Microbiol Infect. 2015;21(5):469.e1–e10. doi:10.1016/j.cmi.2014.12.013
   Web of Science ®Google Scholar
• Temkin E, Fallach N, Almagor J, et al. Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. Lancet Glob Health. 2018;6(9):e969–e979. doi:10.1016/S2214-109X(18)30278-X30103998
   PubMed Web of Science ®Google Scholar
• Pitout JDD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59(10):5873–5884. doi:10.1128/AAC.01019-1526169401
   PubMed Web of Science ®Google Scholar
• Davarci I, Senbayrak S, Aksaray S, Kocoglu ME, Kuskucu MA, Samasti M. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates. Anadolu Klinigi. 2019;24(1):1–7. doi:10.21673/anadoluklin.423081
   Google Scholar
• Koeijers JJ, Verbon A, Kessels AGH, et al. Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology. 2010;76(2):336–340. doi:10.1016/j.urology.2010.02.05220494416
   PubMed Web of Science ®Google Scholar
• Sokhn ES, Salami A, Roz AEI, Salloum L, Bahmad HF, Ghssein G. Antimicrobial susceptibilities and laboratory profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates as agents of urinary tract infection in Lebanon: paving the way for better diagnostics. Med Sci (Basel). 2020;8(3):32–42.
   Google Scholar
• Van Driel AA, Notermans DW, Meima A, et al. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period. Eur J Clin Microbiol Infect Dis. 2019;38(11):2151–2158. doi:10.1007/s10096-019-03655-331440915
   PubMed Web of Science ®Google Scholar
• Ravi Shankar P, Balasubramanium R. World Health Organization antimicrobial resistance: global report on surveillance 2014 (Book Review). Australas Med J. 2014;7(5):238–239.
   Google Scholar
• Arnold RS, Thom KA, Sharma S, Phillips M, Kristie Johnson J, Morgan DJ. Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J. 2011;104(1):40–45. doi:10.1097/SMJ.0b013e3181fd7d5a21119555
   PubMed Web of Science ®Google Scholar
• Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti Infect Ther. 2014;12(5):565–580. doi:10.1586/14787210.2014.90230624666262
   PubMed Web of Science ®Google Scholar
• Hu F-P, Guo Y, Zhu D-M, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9–S14. doi:10.1016/j.cmi.2016.01.00127000156
   PubMed Web of Science ®Google Scholar
• Cusack TP, Ashley EA, Ling CL, et al. Time to switch from CLSI to EUCAST? A Southeast Asian perspective. Clin Microbiol Infect. 2019;25(7):782–785. doi:10.1016/j.cmi.2019.03.01630922928
   PubMed Web of Science ®Google Scholar
• Xu A, Zheng B, Xu Y-C, Huang Z-G, Zhong N-S, Zhuo C. National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infect. 2016;22(Suppl 1):S1–S8. doi:10.1016/j.cmi.2015.09.01526846351
   PubMed Web of Science ®Google Scholar
• VITEK®2 (AST-N334) [package insert]. Marcy I’Etoile, France: bioMérieux SA; 2018.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100 Wayne, PA: CLSI; 2019
   Google Scholar
• Khan F, Siddiqui N, Sultan A, Rizvi M, Shukla I, Khan HM. Seasonal variation in Klebsiella pneumoniae blood stream infection: a five year study. Clin Microbiol. 2016;5(2):247. doi:10.4172/2327-5073.1000247
   Google Scholar
• Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li. L. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med. 2013;10(11):e1001556. doi:10.1371/journal.pmed.100155624260030
   PubMed Web of Science ®Google Scholar
• Wang X, Xu X, Li Z, et al. An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in Mainland China. Microb Drug Resist. 2014;20(2):144–149. doi:10.1089/mdr.2013.010024199986
   PubMed Web of Science ®Google Scholar
• Zhou J, Li G, Ma X, Yang Q, Yi J. Outbreak of colonization by carbapenemase-producing Klebsiella pneumoniae in a neonatal intensive care unit: investigation, control measures and assessment. Am J Infect Control. 2015;43(10):1122–1124. doi:10.1016/j.ajic.2015.05.03826149749
   PubMed Web of Science ®Google Scholar
• Agodi A, Barchitta M, Quattrocchi A, et al. Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008–2013. Antimicrob Resist Infect Control. 2015;4:43–49. doi:10.1186/s13756-015-0087-y26539294
   PubMed Web of Science ®Google Scholar
• Federico MP, Furtado GH. Immediate and later impacts of antimicrobial consumption on carbapenem-resistant Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella spp. in a teaching hospital in Brazil: a 10-year trend study. Eur J Clin Microbiol Infect Dis. 2018;37(11):2153–2158. doi:10.1007/s10096-018-3352-130112695
   PubMed Web of Science ®Google Scholar
• Candevir Ulu A, Kurtaran B, Inal AS, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit. 2015;21:219–224. doi:10.12659/MSM.89251625595166
   PubMed Web of Science ®Google Scholar
• Qu X, Wang H, Chen C, et al. Surveillance of carbapenem-resistant Klebsiella pneumoniae in Chinese hospitals - a five-year retrospective study. J Infect Dev Ctries. 2019;13(12):1101–1107. doi:10.3855/jidc.1179832088697
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wei Z, Wang Y, Hua X, Feng Y, Yu Y. Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole-genome sequencing. Clin Microbiol Infect. 2015;21(11):1001–1007. doi:10.1016/j.cmi.2015.07.00126166545
   PubMed Web of Science ®Google Scholar
• Li H, Zhang J, Liu Y, et al. Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme. Diagn Microbiol Infect Dis. 2014;78(1):63–65. doi:10.1016/j.diagmicrobio.2013.10.00224211218
   PubMed Web of Science ®Google Scholar
• Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66(2):307–312. doi:10.1093/jac/dkq43121131324
   PubMed Web of Science ®Google Scholar
• Zou C, Wei J, Shan B, Chen X, Wang D, Niu S. In vitro activity of ceftazidime-avibactam and aztreonam-avibactam against carbapenem-resistant Enterobacteriaceae isolates collected from three secondary hospitals in Southwest China Between 2018 and 2019. Infect Drug Resist. 2020;13:3563–3568. doi:10.2147/IDR.S27398933116675
   PubMed Web of Science ®Google Scholar
• Wei J, Zou C, Wang D, Huang A, Niu S. Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: a single-center study. J Glob Antimicrob Resist. 2020;22:448–451. doi:10.1016/j.jgar.2020.04.02332387260
   PubMed Web of Science ®Google Scholar
• Deleo FR, Chen L, Porcella SF, et al. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A. 2014;111(13):4988–4993. doi:10.1073/pnas.132136411124639510
   PubMed Web of Science ®Google Scholar